The goal of this project is to elucidate basic mechanisms of eukaryotic translation initiation using structural and other biochemical methods. Eukaryotic translation initiation is highly regulated by elements of the untranslated regions of mRNAs, 5'UTR and 3'UTR, by the cellular concentration of initiation factors, by the action of regulatory proteins and by signaling pathways that are initiated by external messages or cellular events. Dysregulation of translation initiation by elevated levels of initiation factors is found in many forms of cancer. Thus, correcting for out-of-balance initiation with small molecule agents is a promising new route for cancer therapy. The proposed research is focused on the mechanisms by which the small ribosomal particle is recruited to mRNA, mediated by the initiation factors eIF4E, eIF4G and the regulatory phosphoprotein 4EBP-1. The second aspect is focused on scanning of the pre-initiation complex to the AUG initiation codon, aided by the interplay between the initiation factors eIF4A, eIF4G and eIF4H. The third topic is on elucidating the interaction of the Mnk1/2 kinases with the HEAT3 domain of eIF4G and its role in phosphorylating eIF4E, which has been related to metastasis. A significant aspect is to discover and characterize inhibitors of initiation with the goal of developing anti-cancer agents with broad specificity. The research will pursue three specific aims: 1. Regulation of the eIF4E/eIF4G interaction by 4EBP proteins and inhibitors 2. Analyze and target the eIF4G interactions with eIF4A, RNA and eIF4H. 3. Inhibit eIF4G-MNK1/2 interaction to prevent eIF4E phosphorylation and cancer metastases.

Public Health Relevance

We will study mechanisms of eukaryotic translation initiation. This will define how the recruitment of the 40S ribosome is regulated by the tumor suppressor 4E-BP1 and by small inhibitors. We also will study the complex of the scaffold protein eIF4G with the RNA helicase eIF4A and MNK1/2 kinases.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA200913-03S1
Application #
9598125
Study Section
Macromolecular Structure and Function C Study Section (MSFC)
Program Officer
Schwartz, Elena Ivan
Project Start
2016-07-20
Project End
2021-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Harvard Medical School
Department
Biochemistry
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
O'Day, Elizabeth M; Idos, Greg E; Hill, Collin et al. (2018) Cytidine monophosphate N-acetylneuraminic acid synthetase enhances invasion of human triple-negative breast cancer cells. Onco Targets Ther 11:6827-6838
Yi, Tingfang; Wagner, Gerhard (2018) Cytocapsular tubes conduct cell translocation. Proc Natl Acad Sci U S A 115:E1137-E1146
Sekiyama, Naotaka; Boeszoermenyi, Andras; Arthanari, Haribabu et al. (2017) 1H, 13C, and 15N backbone chemical shift assignments of 4E-BP144-87 and 4E-BP144-87 bound to eIF4E. Biomol NMR Assign 11:187-191